Comparison of oxybutynin, electrostimulation of the posterior tibial nerve and perineal exercises in the treatment of overactive bladder syndrome

Authors

DOI:

https://doi.org/10.1590/1809-2950/17020026022019

Keywords:

Overactive Bladder Syndrome, Physiotherapy Modalities, Transcutaneous Electrical Stimulation

Abstract

The objective of this study was to evaluate the efficacy of perineal exercises, transcutaneous electrostimulation of the posterior tibial nerve (TPTNS) and oxybutynin in women with overactive bladder syndrome, which is the second most common cause of urinary incontinence, with extremely uncomfortable urinary symptoms which impair their quality of life. A total of 65 women were randomized, of whom 57 completed treatment. Three groups were formed: the perineal exercises group, the TPTNS group and the control group, which used oxybutynin. The exercises were performed in groups, in the standing, supine and sitting positions, twice a week in 30-minute sessions, totaling 12 sessions. In the TPTNS group, carried out with 10Hz frequency and 200 microsecond pulse width, a transcutaneous electrode was positioned on the patients’ medial malleolus, and another was positioned 10cm above it. The patients of the control group received 10 mg/day doses of immediate release oxybutynin, divided into two 5mg/day doses for 12 consecutive weeks. Before and after the treatments, the patients’ voiding diary was analyzed, their pelvic floor was functionally evaluated and they were asked to fill in an OAB-V8 quality of life questionnaire. Urge incontinence was reduced by 50%, 70.5% and 41% in the exercises, TPTNS and oxybutynin groups, respectively, and statistical significance was detected for stimulation only. The three treatment modalities were effective for improving quality of life in the short-term therapy, and were statistically similar to each other.

Downloads

Download data is not yet available.

References

Pan American Health Organization. Health in the Americas 2012

edition: regional outlook and country profiles. Washington, DC:

Pan American Health Organization; 2012.

World Health Organization. Global status report on

noncommunicable diseases 2014. Geneva: World Health

Organization; 2014.

Ministério da Saúde (BR). Secretaria de Vigilância em Saúde.

Departamento de Análise e Situação de Saúde. Plano de ações

estratégicas para o enfrentamento das doenças crônicas

não transmissíveis (DCNT) no Brasil, 2011-2022. Brasília, DF:

Ministério da Saúde; 2011.

World Health Organization. Fact sheets: noncommunicable

diseases. Geneva: World Health Organization; 2015.

Oliveira JEP, Vencio S, editors. Diretrizes da Sociedade Brasileira

de Diabetes: 2014-2015. São Paulo: AC Farmacêutica; 2015.

World Health Organization. Definition, diagnosis and

classification of diabetes mellitus and its complications: report

of a WHO Consultation. Part 1: diagnosis and classification of

diabetes mellitus. Geneva: World Health Organization; 1999.

American Diabetes Association. Diagnosis and classification

of diabetes mellitus. Diabetes Care. 2013;36(1):S67-74. doi:

2337/dc13-S067

Vukojević Z, Pekmezović T, Nikolić A, Perić S, Basta I, Marjanović,

et al. Correlation of clinical and neurophysiological findings

with health related quality of life in patients with diabetic

polyneuropathy. Vojnosanit Pregl. 2014;71(9):833-8. doi:

2298/VSP120919015V

Mochizuki Y, Tanaka H, Matsumoto K, Sano H, Toki H, Shimoura

H, et al. Association of peripheral nerve conduction in diabetic

neuropathy with subclinical left ventricular systolic dysfunction.

Cardiovasc Diabetol. 2015;14:47. doi: 10.1186/s12933-015-0213-4

Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R,

Kammerer C, et al. Accelerated loss of skeletal muscle strength

in older adults with type 2 diabetes: the health, aging, and

body composition study. Diabetes Care. 2007;30(6):1507-12.

doi: 10.2337/dc06-2537

Sacchetti MS, Balducci S, Bazzucchi I, Carlucci F, Palumbo A,

Haxhi J, et al. Neuromuscular dysfunction in diabetes: role of

motor nerve impairment and training status. Med Sci Sports

Exerc. 2013;45(1):52-9. doi: 10.1249/MSS.0b013e318269f9bb

Orlando G, Balducci S, Bazzucchi I, Pugliese G, Sacchetti M.

Neuromuscular dysfunction in type 2 diabetes: underlying

mechanisms and effect of resistance training. Diabetes Metab

Res Rev. 2016;32(1):40-50. doi: 10.1002/dmrr.2658

Balducci S, Sacchetti M, Orlando G, Salvi L, Pugliese L, Salerno

G, et al. Correlates of muscle strength in diabetes: the study on

the assessment of determinants of muscle and bone strength

abnormalities in diabetes (SAMBA). Nutr Metab Cardiovasc

Dis. 2014;4(1):18-26. doi: 10.1016/j.numecd.2013.04.010

Parmenter BJ, Raymond J, Dinnen PJ, Lusby RJ, Singh

MAF. Preliminary evidence that low ankle-brachial index is

associated with reduced bilateral hip extensor strength and

functional mobility in peripheral arterial disease. J Vasc Surg.

;57(4):963-73. doi: 10.1016/j.jvs.2012.08.103

Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen

H. Accelerated atrophy of lower leg and foot muscles: a followup study of long-term diabetic polyneuropathy using magnetic

resonance imaging (MRI). Diabetologia. 2009;52(6):1182-91.

doi: 10.1007/s00125-009-1320-0

Allen MD, Kimpinski K, Doherty TJ, Rice CL. Decreased muscle

endurance associated with diabetic neuropathy may be

attributed partially to neuromuscular transmission failure. J Appl

Physiol. 2015;118(8):1014-22. doi: 10.1152/japplphysiol.00441.2014

Ijzerman TH, Schaper NC, Melai T, Meijer K, Willems PJB,

Savelberg HHCM. Lower extremity muscle strength is reduced in

people with type 2 diabetes, with and without polyneuropathy,

and is associated with impaired mobility and reduced quality

of life. Diabetes Res Clin Pract. 2012;95(3):345-51. doi: 10.1016/j.

diabres.2011.10.026

Bianchi L, Zuliani G, Volpato S. Physical disability in the elderly

with diabetes: epidemiology and mechanisms. Curr Diab Rep.

;13(6):824-30. doi: 10.1007/s11892-013-0424-6

Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois

JA, Engelgau MM, et al. Diabetes and physical disability among

older U.S. adults. Diabetes Care. 2000;23(9):1272-7. doi: 10.2337/

diacare.23.9.1272

Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DIW,

Cooper C. Type 2 diabetes, muscle strength, and impaired

physical function: the tip of the iceberg? Diabetes Care.

;28(10):2541-2. doi: 10.2337/diacare.28.10.2541

Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle

strength in type 2 diabetes. Diabetes. 2004;53(6):1543-8. doi:

2337/diabetes.53.6.1543

Bokan V. Muscle weakness and other late complications of

diabetic polyneuropathy. Acta Clin Croat [Internet]. 2011 [cited

Apr 24];50(3):351-5. Available from: hrcak.srce.hr/84096

Halvatsiotis P, Short KR, Bigelow M, Nair KS. Synthesis rate of

muscle proteins, muscle functions, and amino acid kinetics in

type 2 diabetes. Diabetes. 2002;51(8):2395-404. doi: 10.2337/

diabetes.51.8.2395

Andreassen CS, Jakobsen J, Andersen H. Muscle weakness:

a progressive late complication in diabetic distal symmetric

polyneuropathy. Diabetes. 2006;55(3):806-12. doi: 10.2337/

diabetes.55.03.06.db05-1237

Hawley J, Zierath JR, editors. Physical activity and type 2

diabetes: therapeutic effects and mechanisms of action.

Champaign: Human Kinetics; 2008.

Park SW, Goodpaster BH, Strotmeyer ES, Rekeneire N, Harris

TB, Schwartz AV, et al. Decreased muscle strength and quality

in older adults with type 2 diabetes: the health, aging, and body

composition study. Diabetes. 2006;55(6):1813-8. doi: 10.2337/

db05-1183

Harbo T, Brincks J, Andersen H. Maximal isokinetic and isometric

muscle strength of major muscle groups related to age, body

mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol.

;112(1):267-75. doi: 10.1007/s00421-011-1975-3

Jones EJ, Bishop PA, Woods AK, Green JM. Cross-sectional

area and muscular strength: a brief review. Sports Med.

;38(12):987-94. doi: 10.2165/00007256-200838120-00003

Boshra H, Bahrpeyma F, Tehrani MRM. The comparison of

muscle strength and short term endurance in the different

periods of type 2 diabetes. J Diabetes Metab Disord. 2014;13:22.

doi: 10.1186/2251-6581-13-22

Ijzerman TH, Schaper NC, Melai T, Blijham P, Meijer K, Willems

PJB, et al. Motor nerve decline does not underlie muscle

weakness in type 2 diabetic neuropathy. Muscle Nerve.

;44(2):241-5. doi: 10.1002/mus.22039

Allen MD, Major B, Kimpinski K, Doherty TJ, Rice CL. Skeletal

muscle morphology and contractile function in relation to

muscle denervation in diabetic neuropathy. J Appl Physiol.

;116(5):545-52. doi: 10.1152/japplphysiol.01139.2013

Published

2019-05-05

Issue

Section

Original Research

How to Cite

Comparison of oxybutynin, electrostimulation of the posterior tibial nerve and perineal exercises in the treatment of overactive bladder syndrome. (2019). Fisioterapia E Pesquisa, 26(2), 127-136. https://doi.org/10.1590/1809-2950/17020026022019